by TractManager | Sep 30, 2021 | Precision Medicine Insights
This report reviews clinical study abstracts and clinical practice guidelines addressing genetic testing for facioscapulohumeral muscular dystrophy (FSHD).If you have a Hayes login, click here to view the full report on the Knowledge Center.
by TractManager | Sep 27, 2021 | Evolving Evidence Review
This report addresses whether full-text clinical studies, systematic reviews, and clinical practice guidelines and position statements support the use of ENROUTE Transcarotid Stent with Neuroprotective System compared with open carotid endarterectomy (CEA) procedure...
by TractManager | Sep 27, 2021 | Health Technology Assessment
Focus of the Report: This health technology assessment focuses on the use of an absorbable perirectal spacer (APS) (SpaceOAR; Boston Scientific) to prevent rectal toxicity in patients undergoing radiation therapy (RT) for prostate cancer (PCa).Technology Description:...
by TractManager | Sep 23, 2021 | Clinical Utility Evaluation
This report evaluates the clinical utility of cell-free DNA (cfDNA) (formerly NIPS, NIPT) screening for fetal sex chromosome aneuploidy (SCA) in women with singleton or twin pregnancies.If you have a Hayes login, click here to view the full report on the Knowledge...
by TractManager | Sep 21, 2021 | Emerging Technology Report
Tivdak (tisotumab vedotin-tftv) is an intravenously administered tissue factor-directed antibody and microtubule inhibitor conjugate indicated for the treatment of adult patients with recurrent or metastatic cervical cancer with disease progression on or after...
Recent Comments